FdCyd
Tier C — Watch / tradeFdCyd
Targets：DNMT1
Indications (approved)：Non-small cell lung cancer, Lung cancer, Myelodysplastic syndrome, Acute myeloid leukaemia, 间皮组织肿瘤, Oesophageal cancer, Bladder cancer, Breast cancer
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| FdCyd-001 | 50-91-9 | 5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
| FdCyd-002 | 7207-56-9 | ((2R,3S,5R)-3-acetoxy-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate |
| FdCyd-003 | 161179-94-8 | ((2R,3S,5R)-3-acetoxy-5-(5-fluoro-2-oxo-4-(1H-1,2,4-triazol-1-yl)pyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl acetate |
| FdCyd-004 | 161179-95-9 | 4-ethoxy-5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one |
Frequently asked questions
What are the approved indications of FdCyd?
Approved indications include: Non-small cell lung cancer, Lung cancer, Myelodysplastic syndrome, Acute myeloid leukaemia, 间皮组织肿瘤, Oesophageal cancer, Bladder cancer, Breast cancer.
When does the FdCyd patent expire?
No public expiry year is available for FdCyd yet; this page updates once verified.
How many synthesis routes are recorded for FdCyd?
1 synthesis routes are recorded; the shortest is 4 steps with 0.44 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy FdCyd intermediates?
All intermediates in FdCyd routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for FdCyd intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21